Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017, Article ID 3091973, 3 pages
https://doi.org/10.1155/2017/3091973
Case Report

A Rare Case of Paraneoplastic Aortitis Associated with Chronic Myelomonocytic Leukemia

1Division of Rheumatology, Cooper University Hospital, Camden, NJ, USA
2Division of Hematology-Oncology, MD Anderson Cancer Center, Cooper University Hospital, Camden, NJ, USA

Correspondence should be addressed to Sylwia Sasinowska; ude.htlaehrepooc@aiwlys-akswonisas

Received 3 January 2017; Revised 3 April 2017; Accepted 24 April 2017; Published 25 May 2017

Academic Editor: Akimichi Ohsaka

Copyright © 2017 Sylwia Sasinowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. L. Gornik and M. A. Creager, “Aortitis,” Circulation, vol. 117, no. 23, pp. 3039–3051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Mori, K. Togami, H. Fujita et al., “Successful allogeneic bone marrow transplantation for chronic myelomonocytic leukemia complicated by refractory aortitis,” Bone Marrow Transplantation, vol. 45, no. 4, pp. 796-797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. K. Park, A. C. Gelber, G. Zheng, M. A. McDevitt, C. D. Gocke, and A. N. Baer, “Large-vessel vasculitis as an early manifestation of chronic myelomonocytic leukemia,” Journal of Clinical Oncology, vol. 29, no. 20, pp. e601–e603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Fleming, E. Hellström-Lindberg, K. Burbury, and J. F. Seymour, “Paraneoplastic large vessel arteritis complicating myelodysplastic syndrome,” Leukemia and Lymphoma, vol. 53, no. 8, pp. 1613–1616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Steurer, G. Fritsche, A. Tzankov et al., “Large-vessel arteritis and myelodysplastic syndrome: report of two cases,” European Journal of Haematology, vol. 73, no. 2, pp. 128–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Selimoglu-Buet, O. Wagner-Ballon, V. Saada et al., “Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia,” Blood, vol. 125, no. 23, pp. 3618–3626, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Arber, A. Orazi, R. Hasserjian et al., “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia,” Blood, vol. 127, no. 20, pp. 2391–2405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Grignano, A. Mekinian, T. Braun et al., “Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: a series of 26 cases and literature review,” Leukemia Research, vol. 47, pp. 136–141, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Vardiman, N. L. Harris, and R. D. Brunning, “The World Health Organization (WHO) classification of the myeloid neoplasms,” Blood, vol. 100, no. 7, pp. 2292–2302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Hamidou, A. Boumalassa, C. Larroche, D. E. Kouri, O. Blétry, and J.-Y. Grolleau, “Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia,” Seminars in Arthritis and Rheumatism, vol. 31, no. 2, pp. 119–126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Braun and P. Fenaux, “Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?” Best Practice & Research Clinical Haematology, vol. 26, no. 4, pp. 327–336, 2013. View at Publisher · View at Google Scholar
  12. O. Al Ustwani, L. A. Ford, S. J. N. Sait et al., “Myelodysplastic syndromes and autoimmune diseases—case series and review of literature,” Leukemia Research, vol. 37, no. 8, pp. 894–899, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Onida and M. Beran, “Chronic myelomonocytic leukemia: myeloproliferative variant,” Current Hematology Reports, vol. 3, no. 3, pp. 218–226, 2004. View at Google Scholar
  14. A. Mekinian, E. Grignano, T. Braun et al., “Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicenter retrospective study,” Rheumatology, vol. 55, pp. 291–300, 2016. View at Google Scholar